Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer (NCT04266886)
Integration of Self-Hypnosis in an Enhanced Recovery After Surgery (ERAS) Program: A Prospective Randomized Trial
🩺 Plain-English Summary (8th-Grade Level)
This trial studies how well self-hypnosis works in enhancing recovery after surgery in patients with gynecologic cancer. A guided relaxation method called self-hypnosis may help affect how patients feel pain and symptoms after surgery.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (9 items).
Location: M D Anderson Cancer Center — Houston, Texas
Age range: 18 Years
🧪 Interventions in This Study
- Best Practice (OTHER)
- Hypnotherapy (PROCEDURE)
- Quality-of-Life Assessment (OTHER)
- Questionnaire Administration (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Sensitivity to amide-type local anesthetics
- Patients on long-acting opioid medications, or scheduled (four or more times a day for seven or more days) short-acting opioid medications within the last 30 days
- Emergency surgery of any type that does not allow for proper time for protocol review by the patient
- Surgery that involves known/anticipated resection of anterior abdominal wall with plastic surgery reconstruction
- Patients undergoing known/anticipated anterior abdominal wall hernia repairs
- Patients undergoing pelvic exenteration
- Patients with known major psychiatric disease
- Patients with hearing impairment such that they are unable to hear the intervention
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- M D Anderson Cancer Center — Houston, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Malignant Female Reproductive System Neoplasm
- Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic — Santo Domingo,
- An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors — Atlanta, Georgia
- e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study — Duarte, California
- Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery — Rochester, Minnesota
- Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers — Baltimore, Maryland
Explore by condition: All Malignant Female Reproductive System Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.